| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $630.0M | — | +29.4% |
| Cost of Revenue | $496.6M | — | +22.1% |
| Gross Profit | $133.4M | — | +66.7% |
| R&D Expense | $43.0M | — | -1.3% |
| SG&A Expense | $81.2M | — | +33.0% |
| Operating Income | $6.5M | — | +126.5% |
| Pre-tax Income | $19.8M | — | +217.6% |
| Income Tax | $615K | — | +310.0% |
| Net Income | $2.6M | — | +174.9% |
| EPS (Basic) | $0.02 | — | +166.7% |
| EPS (Diluted) | $0.02 | — | +166.7% |
| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.82B | +46.1% | +101.4% |
| Accounts Receivable | $107.6M | -42.4% | -19.9% |
| Inventory | $183.7M | +11.7% | +69.0% |
| Current Assets | $2.46B | +30.0% | +68.6% |
| Total Assets | $2.99B | +24.7% | +74.5% |
| Current Liabilities | $1.78B |
| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $191.5M | — | -6.6% |
| Investing Cash Flow | -$40.6M | — | -60.1% |
| Financing Cash Flow | $423.1M | — | — |
| +49.0% |
| Total Liabilities | $2.03B | +6.0% | +53.9% |
| Stockholders' Equity | $663.8M | +199.9% | +237.7% |